tirzepatide and kidney function (Zepbound) showed improved in obese patients with both chronic kidney disease #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https tirzepatide hfpef 🧬 New data

Siempre que sea posible, utilizar estas fuentes oficiales puede reducir el riesgo de encontrarse con publicidad engaosa o productos no verificados

Track progress through multiple metrics: scale weight (understanding water fluctuations affect this), body measurements at consistent points, progress photos in consistent lighting and posture, and subjective assessments of how clothing fits

has received research grants from Boehringer Ingelheim, Merck, Mylan Pharmaceuticals, Novo Nordisk, Pfizer and Sanofi US Services, has served as a consultant for AstraZeneca, Bayer Healthcare Pharmaceuticals, Biomea, Boehringer Ingelheim, Carmot, Eli Lilly, Intarcia, Intercept Pharmaceuticals, Janssen Global Services, Johnson & Johnson Medical Devices & Diagnostics Group-Latin America, MannKind Corporation, Merck, Novo Nordisk, Pfizer, Sanofi US Services, Shionogi, StructureTherapeutics, Target Pharma, Valeritas and Zealand Pharma, and has received travel expenses from Boehringer Ingelheim, Eli Lilly, Johnson & Johnson Medical Devices & Diagnostics Group-Latin America, Novo Nordisk, Sanofi US Services and Zealand Pharma

Besides the fact that he is trying to sit in a doctors chair, he is somewhat wrong